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The Small Business Innovation research (SBIr) Program is a national competitive funding 
program, authorized by the United States Congress in 98 to stimulate and facilitate 
research and development by US-owned and operated for-profit small businesses. all 
executive-branch departments with extramural research budgets exceeding $00 million 
are directed by legislation to provide a .5% set-aside to fund SBIr programs. Small 
businesses are defined as having 500 employees or less.
The United States Department of agriculture (USDa) Cooperative State research, 
Education, and Extension Service (CSrEES) manages the SBIr Program. The USDa-
SBIr Program awards only grants. It is a three-phase program. Phase I is a feasibility 
(proof-of-concept) study, and for FY007 the grant may be for eight months for up to 
$80,000. Successful Phase I award winners are eligible to apply for Phase II funding. 
Phase II proposals are for a full r&D project leading to the development of a working 
product, process, or service that will be ready for final commercial application in the 
private sector. For FY007 Phase II awards are for up to 4 months and up to $350,000. 
Phase III is the actual commercialization phase and no federal funding is used. Histori-
cally, companies winning SBIr grants have been successful in leveraging the SBIr seed 
money and the technical credibility conferred by a confidential and rigorous peer-review 
process to attract additional investment dollars from private sector entities. almost half 
of the companies receiving USDa-SBIr Phase II awards have gone on to have some level 
of commercial sales based on their project.
The USDA Small Business Innovation Research 




All executive-branch departments with extramural research 
budgets exceeding $100 million are directed by legislation 
to provide a 2.5% set-aside to fund SBIR programs.
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The USDa-SBIr Program strongly encourages the participation of university and 
government scientists in SBIr projects. These scientists may serve as consultants or 
subcontractors with funding not exceeding a third of Phase I awards or a half of Phase 
II awards. a public-sector scientist may serve as the principal investigator on an SBIr 
grant by reducing employment at her/his home institution to 49% for the duration of 
the grant and if the SBIr research is performed someplace other than her/his lab. It is 
usually not acceptable for a university or government scientist to serve as a consultant 
and have all the research proposed for the grant done in her/his lab.
The funding level for the USDa-SBIr Program FY0006 was $9.7 million (table 
). In 006, 650 Phase I proposals were received and approximately 6% (0) were 
recommended for funding (table ). During the same year thirty-three of sixty-one Phase 
II proposals were funded (54%, table ).
Table 1. usda-sbiR pRogRam funding hisToRy.
 Year Budget Phase I Phase II
  ($million)
 999 3.3 84/45 3/56  
 000 5.6 89/480 36/59  
 00 6.3 90/480 37/63  
 00 5.7 86/449 39/68  
 003 7.7 88/656 38/67  
 004 8. 99/58 38/65  
 005 9. 93/557 40/79  
 006 9. 0/650 33/6`
Proposals funded. Proposals submitted.
Investigator-initiated concepts make up the bulk of the proposals received by the 
USDa-SBIr Program. The Program has twelve broad topic areas that are outlined in the 
request for applications (rFa) form (accessible at http://www.csrees.usda.gov/fo/sbir). Of 
these topic areas, nine routinely field biotechnology proposals (table ). This presentation 
will focus on opportunities and challenges facing researchers submitting biotechnology 
proposals to two USDa-SBIr topic areas, Plant Production and Protection – Biology 
and Industrial applications.
Table 2. bioTechnology-RelevanT usda-sbiR Topic aReas
 Forest & related resources aquaculture  
 Plant Production & Protection–Biology Industrial applications  
 animal Production & Protection animal Manure Management  
 Water & Soil resources Plant Production & Protection–Engineering  
 Food Science & Nutrition
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Plant Production and Protection–Biology
SBIr topic area 8., Plant Production and Protection–Biology (P3B), has three main 
subtopics:
• Improved Crop Quality and Yield Utilizing Innovative applications of Plant 
Breeding, Molecular Biology, Genomics, and Cell and tissue Biology;
• Development of New Crops as Sources of Food, Fiber, or Industrial Products; 
and
• Crop Protection from Insects, Disease, and abiotic Stress.
The USDa-SBIr web site (http://www.csrees.usda.gov/fo/sbir) provides access to abstracts 
of funded research and success stories that are illustrative of the scope of projects receiv-
ing funding in this topic area. From FY005–007 “specialty crops” have been a special 
focus of the P3B topic area solicitation. Examples of specialty crops are fruits, vegetables, 
nuts, ornamental nursery or greenhouse crops, and forest trees (e.g. american chestnut). 
typically, specialty crops have a much lower per-crop market value than the major row 
crops (e.g. corn, soybean). However, taken together they make up fully half of the US 
annual agricultural output, ~$50 billion (Jerardo, 005). The P3B topic area encourages 
submission of FY007 proposals in four specialty-crop focus areas:
• improved plant-disease diagnostics;
• improved disease resistance in specialty crops;
• biological approaches to improve floriculture and ornamental nursery production; 
and
• rapid diagnostic methods for weedy and invasive species.
although there is great opportunity for small businesses to use the tools and methods 
of biotechnology to create valuable new specialty-crop genotypes, there are significant 
challenges, as well. One aspect of the pre-commercial development of any new biotech-
nology-derived crop is navigating the regulatory process, which may involve interacting 
with as many as three federal agencies [USDa-animal and Plant Health Inspection 
Service (aPHIS), Environmental Protection agency (EPa), and Food and Drug admin-
istration (FDa)]. The time involved and the financial expense of developing a complete 
dossier for seeking regulatory approval (deregulation) can be daunting. to date, only a 
small number of transgenic biotechnology-derived specialty crops have been deregulated 
and allowed to proceed to market (Goldner et al., 005).  Even more troubling is the 
trend in research to develop specialty crops. Field-trial requests to aPHIS for transgenic 
vegetables peaked in the mid-late 990s with as many as 0 requests, but by late 004, 
it had fallen to approximately twenty (Figure ). US taxpayers have invested heavily in 
agricultural biotechnology through the USDa agricultural research Service (arS) and 
through funding provided to land-grant universities, other public and private universities, 
and small agricultural biotechnology companies through USDa CSrEES. Where is the 
return on that investment (McHughen, 005)?
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Biotechnology grants funded by the SBIr Program from FY998 through FY006 are 
shown in Figure . One to five Phase I grants in plant biology (P3B) have been funded 
during that period (Figure ). However, Phase II awards in plant biotechnology receiving 
peaked in FY000 (three), with single awards funded in FY00 and FY003 (Figure ). 
Since 003, no Phase II award has been granted to a transgenic-technology project in plant 
Figure . US transgenic fruit and vegetable field trials 987 to October 004 
(redenbaugh, 005)
Figure . USDa-SBIr biotechnology grants.
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biology, despite twelve projects being eligible to apply for Phase II in the FY004–006 
period (Figure ). Only 0% of eligible P3B Phase I projects went to Phase II in the period 
FY999–004 (Figure , Phase I projects awarded in FY005–006 are still eligible to 
apply for Phase II in FY007). Part of the explanation for the low percentage of Phase I 
projects competing successfully for Phase II may be the increased emphasis on commercial 
potential that the SBIr Leadership team developed beginning in FY003. If it could 
not be demonstrated how the results of a project would provide a marketable product, 
overcoming technical and regulatory challenges, there would be reduced incentive for the 
reviewing community to recommend investment. The question is, “How can we improve 
the chances for a broad range of biotechnology-derived specialty crops to reach the market 
place, where market forces will determine their acceptability to the public?”
the Specialty Crops regulatory Initiative
Motivated by concerns and circumstances outlined above, a team of public- and private-
sector scientists and administrators have been working on a program since 003, The 
Specialty Crops regulatory Initiative (SCrI). The over-arching rationale behind SCrI is 
to facilitate realization of potential to make available a broader range of biotech options, 
in a greater diversity of crops, to help meet needs of agriculture, consumers, and the 
environment. toward this end, the approach being considered is to develop an organiza-
tion to assist public-sector and smaller-scale private-sector developers of specialty crops 
through the existing regulatory approval process. Similar programs have been developed 
to facilitate small-market orphan drugs (FDa) and small-acreage pesticides (USDa, Ir-
4). Specialty traits of major crops (e.g. industrial lubricants, value-added proteins) share 
similar developmental challenges with specialty crops (e.g. smaller market size). at this 
time, including specialty traits of major crops under the specialty-crops umbrella has 
neither been ruled in or out.
The over-arching rationale behind SCRI is to facilitate 
realization of potential to make available a broader range of 
biotech options, in a greater diversity of crops, to help meet needs 
of agriculture, consumers, and the environment.
The long-term challenge for SCrI will be to make available a broader range of biotech 
crop options that create public benefit and meet economic and environmental needs 
(Goldner et al., 005). The need for the SCrI is underscored by the diversity of the SCrI 
steering committee including members from the public sector—USDa-CSrEES, arS, 
and aPHIS, and land-grant universities (86s and 890s), as well as technology develop-
ers, commodity groups and growers from the private sector. The SCrI steering committee 
organized and implemented two national workshops to develop the concept and obtain 
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stakeholder input, and have informed numerous scientific and industry groups about the 
SCrI model. a significant milestone in the realization of SCrI was recently achieved 
with the selection and hiring of a consultant, through a contract with the University of 
California-riverside. The consultant will serve as project manager to obtain additional 
stakeholder input and support to develop an action plan for realizing SCrI’s potential 
public benefit. While the SCrI is potentially an important entity for providing guidance 
and assistance in developing critical data sets for specialty crop developers preparing ap-
plications for the deregulation of biotechnology-derived specialty crops under the current 
regulatory system, the implementation of SCrI remains several years in the future.
alternative approaches to Developing Specialty Biotech Crops
Despite the decline in SBIr-funded plant biotechnology projects reaching Phase II in the 
past 3–4 years, there have been some SBIr projects with technical approaches that partially 
mitigate risk through the implementation of confinement technologies. two examples are 
CEa Systems, Ithaca, NY, and Kuehnle agrosystems Co., Honolulu, HI. 
CEa Systems’s technology platform was developed at Cornell University. Essentially, the 
target production of high-value proteins from transgenic plants in controlled environment 
hydroponic systems (i.e. greenhouse, growth chamber). CEa is using SBIr P3B funding 
to understand the effects of environment on protein expression in their target crops. 
The value of the proteins being manufactured is great enough to create a commercially 
viable opportunity on a greenhouse scale (small acreage) using controlled environment 
technology to prevent inadvertent environmental release.
Kuehnle agrosystems (Ka) has developed a system of “green biofactories.” Their pro-
prietary genetic transformation technology—magnetophoresis—was developed through 
funding from SBIr P3B Phase I and Phase II grants. Magnetophoresis allows specific plant 
tissues or organelles to be transformed resulting in new or optimized metabolic function. 
Ka received an SBIr Industrial applications Phase I grant to begin developing the use 
of magnetophoresis to create green biofactories using transgenic unicellular algae that 
are grown and contained in controlled environment systems. These algae will be capable 
of producing high-value proteins and other compounds that will justify their relatively 
small scale of production. The reduced environmental risk conferred by the Ka and 
CEa controlled-environment approach may facilitate the deregulation of their respective 
biotechnology-derived genotypes to be used exclusively in these systems.
Industrial applications
The USDa-SBIr 8.8 Industrial applications topic area provides r&D funding oppor-
tunities to companies that are developing enhanced production technology, improved 
quality control, and new biobased products from agricultural materials and residues. For 
FY007, the Industrial applications program established some specific focus areas: biofu-
els (e.g. ethanol, fuel gas, hydrogen); biobased products improving the economics of the 
biofuel production stream; and the development of new energy crops. USDa plays a lead 
role in the development of biofuel feedstocks and biomass-conversion technology. Con-
sequently, the SBIr Industrial applications program is fertile ground for biotechnology 
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concepts targeting these areas. Figure  shows that Industrial applications biotechnology 
projects funded by SBIr are on the increase.
The current interest in renewable energy research and development by SBIr was em-
phasized at a conference held July 6–7, 006, at Oak ridge National Labs (OrNL), Oak 
ridge, tN. The Department of Energy (DOE)/USDa-SBIr Energy Summit showcased 
alternative and renewable energy research-funding and technology-transfer opportuni-
ties from OrNL and USDa. approximately 0 scientists and administrators (seventy 
from small businesses) attended the -day conference. Both OrNL (DOE) and the 
USDa-arS have extensive research programs on bioenergy, many of which have strong 
biotechnology components. additionally, the USDa rural Development agency provides 
a number of programs supporting bioenergy company development and sustainability. 
CSrEES also funds university bioenergy research programs through the National re-
search Initiative Competitive Grant Program (www.csrees.usda.gov) and through other 
funding mechanisms. These bioenergy programs may afford new opportunities for small 
biotech companies to partner with these public-sector research institutions to bring new 
technologies into application in the private sector.
additional USDa-SBIr Program Information
The USDa-SBIr Program releases one annual solicitation (usually June ) with a closing 
date usually 90 days after the release (usually September ). Phase I proposals are reviewed 
by outside reviewers and funding recommendations are provided by a technical review 
panel. Proposals are submitted electronically. Each applicant receives a verbatim copy of 
the review and a summary of the panel discussion. 
The twelve SBIr topic areas are: Forests and related resources; Plant Production and 
Protection–Biology; animal Production and Protection; Soil and Water resources; Food 
Science and Nutrition: rural and Community Development; aquaculture; Industrial 
applications; Marketing and trade; animal Manure Management; and Small and Mid-
Size Farms. The website (www.csrees.usda.gov/fo/sbir) may be used to access program 
information, the rFa, technical project abstracts, links to the Small Business administra-
tion and other SBIr programs, and USDa-SBIr Success Stories.
Closing thoughts
• USDa-SBIr projects are effective technology-transfer mechanisms for moving 
publicly developed technology into private-sector applications that benefit various 
aspects of american agriculture and rural america.
The USDA Rural Development Agency provides a number 
of programs supporting bioenergy company development and 
sustainability.
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• royalties and licensing revenues from many SBIr projects accrue to our univer-
sity partners and other public technology developers (e.g. arS).
• agricultural biotechnology projects need to be carefully thought out to be com-
petitive in Phase II (commercialization).
• Opportunities are growing for agricultural biotech applications targeting energy-
related industrial applications.
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